Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting.

Moloney B, Li X, Hirano M, Saad Eddin A, Lim JY, Biswas D, Kazerouni AS, Tudorica A, Li I, Bryant ML, Wille C, Pyle C, Rahbar H, Hsieh SK, Rice-Stitt TL, Dintzis SM, Bashir A, Hobbs E, Zimmer A, Specht JM, Phadke S, Fleege N, Holmes JH, Partridge SC, Huang W.

Open source

DOI: 10.3389/fonc.2024.1395502
Published: 2024-11-29
Container: Front Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2024.1395502,
  title = {Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting.},
  author = {Moloney B and  Li X and  Hirano M and  Saad Eddin A and  Lim JY and  Biswas D and  Kazerouni AS and  Tudorica A and  Li I and  Bryant ML and  Wille C and  Pyle C and  Rahbar H and  Hsieh SK and  Rice-Stitt TL and  Dintzis SM and  Bashir A and  Hobbs E and  Zimmer A and  Specht JM and  Phadke S and  Fleege N and  Holmes JH and  Partridge SC and  Huang W.},
  year = {2024},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2024.1395502},
  url = {https://doi.org/10.3389/fonc.2024.1395502}
}

RIS

TY  - JOUR
TI  - Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting.
AU  - Moloney B
AU  -  Li X
AU  -  Hirano M
AU  -  Saad Eddin A
AU  -  Lim JY
AU  -  Biswas D
AU  -  Kazerouni AS
AU  -  Tudorica A
AU  -  Li I
AU  -  Bryant ML
AU  -  Wille C
AU  -  Pyle C
AU  -  Rahbar H
AU  -  Hsieh SK
AU  -  Rice-Stitt TL
AU  -  Dintzis SM
AU  -  Bashir A
AU  -  Hobbs E
AU  -  Zimmer A
AU  -  Specht JM
AU  -  Phadke S
AU  -  Fleege N
AU  -  Holmes JH
AU  -  Partridge SC
AU  -  Huang W.
PY  - 2024
JO  - Front Oncol
DO  - 10.3389/fonc.2024.1395502
UR  - https://doi.org/10.3389/fonc.2024.1395502
ER  -

APA

B, M., X, L., M, H., A, S. E., JY, L., D, B., AS, K., A, T., I, L., ML, B., C, W., C, P., H, R., SK, H., TL, R., SM, D., A, B., E, H., A, Z., JM, S., S, P., N, F., JH, H., SC, P., & W., H. (2024). Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting.. Front Oncol. https://doi.org/10.3389/fonc.2024.1395502

Source records

europe-pmc · retrieved 2026-09-26T07:07:50.503Z
doaj · retrieved 2026-09-26T07:07:50.485Z